Answer
The safety and efficacy of vestronidase alfa have not been established in patients older than 65 years, and no alternative dose regimen is recommended for these patients.
Sources for this answer
- Mepsevii 2 mg/mL concentrate for solution for infusionUltragenyx UK · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked